Breaking News: Medicare officials are deciding whether to cover Aduhelm, a controversial new Alzheimer’s drug. The outcome may help decide the drug’s future. - HOT AIR BALLOON FLIGHT

Facebook Twitter RSS Google

Home » breaking news » news » Breaking News: Medicare officials are deciding whether to cover Aduhelm, a controversial new Alzheimer’s drug. The outcome may help decide the drug’s future.

Breaking News: Medicare officials are deciding whether to cover Aduhelm, a controversial new Alzheimer’s drug. The outcome may help decide the drug’s future.

BREAKING NEWS

Medicare officials are deciding whether to cover Aduhelm, a controversial new Alzheimer's drug. The outcome may help decide the drug's future.

Friday, December 31, 2021 11:59 AM EST

Medicare officials are expected to issue their preliminary decision on Aduhelm in January.

The Food and Drug Administration's approval of the drug in June has drawn fierce criticism because clinical trials showed the drug had significant safety risks and unclear benefit to patients.

Read the latest

You received this email because you signed up for NYTimes.com's Breaking News Alerts. To stop receiving these emails, unsubscribe or manage your email preferences.

Subscribe to the Times Get the NYT app

Change Your Email Privacy Policy Contact Advertise California Notice

The New York Times Company, 620 Eighth Avenue, New York, NY 10018